Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound

Summary: Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four...

Full description

Bibliographic Details
Main Authors: Chun-Han Lin, Tiina Jokela, Joe Gray, Mark A. LaBarge
Format: Article
Language:English
Published: Elsevier 2017-10-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124717313487
_version_ 1819010268956459008
author Chun-Han Lin
Tiina Jokela
Joe Gray
Mark A. LaBarge
author_facet Chun-Han Lin
Tiina Jokela
Joe Gray
Mark A. LaBarge
author_sort Chun-Han Lin
collection DOAJ
description Summary: Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. : Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics. Keywords: microenvironment, microenvironment microarray, MEMA, HER2, lapatinib, verteporfin, AZD0530, YAP, fibronectin, breast cancer, drug resistance
first_indexed 2024-12-21T01:09:34Z
format Article
id doaj.art-1672c91d90dc48838b513246a5c203b2
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-21T01:09:34Z
publishDate 2017-10-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-1672c91d90dc48838b513246a5c203b22022-12-21T19:20:57ZengElsevierCell Reports2211-12472017-10-01212533545Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer CompoundChun-Han Lin0Tiina Jokela1Joe Gray2Mark A. LaBarge3Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USADepartment of Population Sciences, City of Hope, Duarte, CA 91010, USA; Center for Cancer Biomarkers, University of Bergen, Bergen 5009, NorwayDepartment of Bioengineering, Oregon Health & Science University, Portland, OR 97201, USADepartment of Population Sciences, City of Hope, Duarte, CA 91010, USA; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; Center for Cancer Biomarkers, University of Bergen, Bergen 5009, Norway; Corresponding authorSummary: Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. : Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics. Keywords: microenvironment, microenvironment microarray, MEMA, HER2, lapatinib, verteporfin, AZD0530, YAP, fibronectin, breast cancer, drug resistancehttp://www.sciencedirect.com/science/article/pii/S2211124717313487
spellingShingle Chun-Han Lin
Tiina Jokela
Joe Gray
Mark A. LaBarge
Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
Cell Reports
title Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
title_full Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
title_fullStr Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
title_full_unstemmed Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
title_short Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound
title_sort combinatorial microenvironments impose a continuum of cellular responses to a single pathway targeted anti cancer compound
url http://www.sciencedirect.com/science/article/pii/S2211124717313487
work_keys_str_mv AT chunhanlin combinatorialmicroenvironmentsimposeacontinuumofcellularresponsestoasinglepathwaytargetedanticancercompound
AT tiinajokela combinatorialmicroenvironmentsimposeacontinuumofcellularresponsestoasinglepathwaytargetedanticancercompound
AT joegray combinatorialmicroenvironmentsimposeacontinuumofcellularresponsestoasinglepathwaytargetedanticancercompound
AT markalabarge combinatorialmicroenvironmentsimposeacontinuumofcellularresponsestoasinglepathwaytargetedanticancercompound